培瑞克

Manufacturing · Pharmaceutical Preparations

完成交易日收盘US$15.7-0.32%行情日期 2026-11-03 · 非实时

公开资料页汇总培瑞克（PRGO）的已发布行情、估值、风险、财务摘要与同业对比。行情截至2026-11-03，非实时；缺失值不按零处理。

股价走势

复权收盘价（美元）

2025-10-31 — 2026-11-03253 个交易日样本

查看交易日数据

2026-11-03PRGOUS$15.7

查看图表数据

日期	PRGO
2025-10-31	18.95
2025-11-03	18.75
2025-11-04	18.44
2025-11-05	13.79
2025-11-06	13.64
2025-11-07	13.19
2025-11-10	13.02
2025-11-11	13.06
2025-11-12	12.94
2025-11-13	12.76
2025-11-14	12.59
2025-11-17	12.39
2025-11-18	12.23
2025-11-19	11.71
2025-11-20	11.2
2025-11-21	11.55
2025-11-24	11.6
2025-11-25	11.8
2025-11-26	12.26
2025-11-28	12.46
2025-12-01	12.93
2025-12-02	12.7
2025-12-03	13.03
2025-12-04	12.59
2025-12-05	12.54
2025-12-08	12.21
2025-12-09	12.43
2025-12-10	12.62
2025-12-11	12.54
2025-12-12	12.26
2025-12-15	11.98
2025-12-16	12.15
2025-12-17	12.47
2025-12-18	12.42
2025-12-19	12.35
2025-12-22	12.55
2025-12-23	12.77
2025-12-24	12.83
2025-12-26	12.9
2025-12-29	12.98
2025-12-30	13.01
2025-12-31	12.99
2026-01-02	12.96
2026-01-05	13.23
2026-01-06	13.77
2026-01-07	13.62
2026-01-08	13.72
2026-01-09	14.08
2026-01-12	13.94
2026-01-13	14.06
2026-01-14	13.87
2026-01-15	14.16
2026-01-16	14.03
2026-01-20	14.08
2026-01-21	13.92
2026-01-22	14.08
2026-01-23	13.74
2026-01-26	13.44
2026-01-27	13.07
2026-01-28	13.02
2026-01-29	12.82
2026-01-30	13.26
2026-02-02	13.37
2026-02-03	13.2
2026-02-04	13.73
2026-02-05	13.32
2026-02-06	13.66
2026-02-09	13.37
2026-02-10	13.43
2026-02-11	13.63
2026-02-12	13.42
2026-02-13	13.57
2026-02-17	13.48
2026-02-18	13.61
2026-02-19	13.9
2026-02-20	13.97
2026-02-23	13.58
2026-02-24	13.64
2026-02-25	13.45
2026-02-26	13.24
2026-02-27	12.34
2026-03-02	11.79
2026-03-03	10.88
2026-03-04	11.17
2026-03-05	10.7
2026-03-06	10.24
2026-03-09	9.83
2026-03-10	9.65
2026-03-11	9.37
2026-03-12	9
2026-03-13	8.88
2026-03-16	9.29
2026-03-17	9.84
2026-03-18	9.5
2026-03-19	9.22
2026-03-20	8.84
2026-03-23	9.14
2026-03-24	9.21
2026-03-25	9.26
2026-03-26	8.96
2026-03-27	9.1
2026-03-30	9.29
2026-03-31	10.26
2026-04-01	10.51
2026-04-02	10.36
2026-04-06	10.12
2026-04-07	10.09
2026-04-08	10.35
2026-04-09	10.13
2026-04-10	10.37
2026-04-13	10.8
2026-04-14	10.96
2026-04-15	10.9
2026-04-16	10.91
2026-04-17	11.27
2026-04-20	11.5
2026-04-21	11.21
2026-04-22	11.29
2026-04-23	11.17
2026-04-24	11.29
2026-04-27	10.98
2026-04-28	11
2026-04-29	10.79
2026-04-30	11.31
2026-05-01	11.39
2026-05-04	10.88
2026-05-05	11.12
2026-05-06	11.71
2026-05-07	11.2
2026-05-08	11.19
2026-05-11	10.58
2026-05-12	10.62
2026-05-13	10.42
2026-05-14	10.36
2026-05-15	10.14
2026-05-18	10.2
2026-05-19	10.14
2026-05-20	10.66
2026-05-21	10.84
2026-05-22	10.72
2026-05-26	10.32
2026-05-27	10.66
2026-05-28	10.93
2026-05-29	10.83
2026-06-01	10.55
2026-06-02	10.25
2026-06-03	10.25
2026-06-04	10.46
2026-06-05	10.62
2026-06-08	11.38
2026-06-09	10.96
2026-06-10	10.95
2026-06-11	10.69
2026-06-12	10.77
2026-06-15	10.49
2026-06-16	10.46
2026-06-17	9.96
2026-06-18	10.05
2026-06-22	9.41
2026-06-23	9.3
2026-06-24	9.57
2026-06-25	9.49
2026-06-26	9.75
2026-06-29	9.85
2026-06-30	10.19
2026-07-01	10.11
2026-07-02	10.8
2026-07-06	10.87
2026-07-07	10.97
2026-07-08	10.31
2026-07-09	10.21
2026-07-10	10.02
2026-07-13	9.97
2026-07-14	9.71
2026-07-15	9.95
2026-07-16	10.94
2026-07-17	10.51
2026-07-20	10.38
2026-07-21	10.26
2026-07-22	10.26
2026-07-23	9.9
2026-07-24	9.89
2026-07-27	9.94
2026-07-28	10.1
2026-07-29	10.23
2026-07-30	10.11
2026-07-31	9.91
2026-08-03	10.47
2026-08-04	10.57
2026-08-05	13.01
2026-08-06	12.29
2026-08-07	12.59
2026-08-10	12.39
2026-08-11	12.6
2026-08-12	12.44
2026-08-13	12.58
2026-08-14	12.78
2026-08-17	12.57
2026-08-18	12.72
2026-08-19	13.69
2026-08-20	13.43
2026-08-21	13.97
2026-08-24	13.99
2026-08-25	14.2
2026-08-26	14.47
2026-08-27	14.09
2026-08-28	14.48
2026-08-31	14.64
2026-09-01	14.43
2026-09-02	14.49
2026-09-03	14.27
2026-09-04	14.92
2026-09-08	14.58
2026-09-09	14.34
2026-09-10	13.59
2026-09-11	13.66
2026-09-14	13.65
2026-09-15	13.56
2026-09-16	13.54
2026-09-17	13.48
2026-09-18	13.56
2026-09-21	14.13
2026-09-22	14.31
2026-09-23	13.84
2026-09-24	14.68
2026-09-25	15.42
2026-09-28	15.1
2026-09-29	15
2026-09-30	14.76
2026-10-01	14.02
2026-10-02	14.26
2026-10-05	14.44
2026-10-06	14
2026-10-07	14.55
2026-10-08	14.5
2026-10-09	15.06
2026-10-12	15.45
2026-10-13	15.37
2026-10-14	15.95
2026-10-15	16.48
2026-10-16	16.63
2026-10-19	16.09
2026-10-20	16.17
2026-10-21	15.91
2026-10-22	16.37
2026-10-23	15.96
2026-10-26	15.82
2026-10-27	16.02
2026-10-28	15.92
2026-10-29	15.9
2026-10-30	15.78
2026-11-02	15.75
2026-11-03	15.7

1、3、6、12个月分别按21、63、126、252个交易日取区间；缺失日期不从区间外补齐。

使用已有每日复权收盘样本，非实时行情；图中价格可能与未复权收盘报价不同。

01 · MARKET FRAME

行情、估值与风险

基于已完成交易日和已发布财务资料

市值US$2.2B

市盈率（TTM）—

自由现金流收益率+6.7%

距52周高点-17.1%

近一年波动率+55.9%

近一年最大回撤-52.9%

区间涨跌幅

10日-2.9%起点 2026-10-20

30日+9.7%起点 2026-09-22

90日+61%起点 2026-06-26

180日+16.5%起点 2026-02-17

250日-14.9%起点 2025-11-04

区间涨跌幅使用复权收盘价；估值和风险指标缺失时显示为—，不按零处理。

02 · FINANCIAL TRACE

财务摘要

公开页仅显示最近3个已校验报告期

年度财务走势

百万美元 · 年度报告期

查看报告期数据

2025-12-31营收4,253.1百万美元

指标	2026-07-31	2026-06-27	2025-12-31	2025-08-01	2025-06-28	2024-12-31	2024-07-31	2024-06-29	2023-12-31
营收	—	—	4,253.1	—	—	4,373.4	—	—	4,655.6
净利润	—	—	-1,425.4	—	—	-171.8	—	—	-12.7
自由现金流	—	—	145.1	—	—	244.6	—	—	303.8
股份数	138.8	—	—	137.6	—	—	136.4	—	—
债务	—	3,294.8	—	—	3,651.9	—	—	4,057.6	—
总资产	—	7,609.5	—	—	10,094.1	—	—	10,397.3	—

客户合同口径 · 营收采用客户合同口径，可能不等同于公司全部收入。

金额及股份数均以百万为单位。缺失或待核验数据不按零处理。

03 · PEER SET

同业对比

同一细分行业中市值最接近的公司

公司	市值	近250日涨跌幅	市盈率	距52周高点	波动率
HRMY哈莫尼生物科学	US$2.2B	+20.5%	11.9×	-13.6%	+39.9%
PVLA帕尔维拉治疗	US$2.2B	+103.7%	—	-3.3%	+83.1%
VERA维拉治疗	US$2.2B	+26.1%	—	-44.8%	+61.6%
AUPH奥瑞尼亚	US$2.2B	+16.1%	7×	-11.1%	+36.6%

同业由已覆盖公司的行业分类和市值接近度确定，仅用于横向研究；缺失数据不按零处理。